Liver cancer half as likey if high level of vitamin D – Feb 2014
Pre-diagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: A nested case-control study
Hepatology DOI: 10.1002/hep.27079
Veronika Fedirko1, Email: ***@****,, Talita Duarte-Salles2, Christina Bamia3, Antonia Trichopoulou3,4, Krasimira Aleksandrova5, Dimitrios Trichopoulos4,6,7, Elisabeth Trepo8, Anne Tjønneland9, Anja Olsen9, Kim Overvad10, Marie-Christine Boutron-Ruault11,12, Françoise Clavel-Chapelon11,12, Marina Kvaskoff11,12, Tilman Kühn13, Annie Lukanova13, Heiner Boeing5, Brian Buijsse5, Eleni Klinaki4, Chrysanthi Tsimakidi4, Alessio Naccarati14, Giovanna Tagliabue15, Salvatore Panico16, Rosario Tumino17, Domenico Palli18, H.Bas Bueno-de-Mesquita19,20,21, Peter D. Siersema20, Petra H. Peters22, Eiliv Lund23, Magritt Brustad23, Karina Standahl Olsen23, Elisabete Weiderpass Vainio23,24,25,26, Raul Zamora27, María-José Sánchez28,29,30, Eva Ardanaz29,31, Pilar Amiano32, Carmen Navarro29,33,34, J.Ramón Quirós35, Mårten Werner36,37, Malin Sund38, Björn Lindkvist39, Johan Malm40, Ruth C Travis41, Kay-Tee Khaw42, Magdalena Stepien2, Augustin Scalbert2, Isabelle Romieu2, Pagona Lagiou3,6, Elio Riboli43, Mazda Jenab2,*
The association between vitamin D status and hepatocellular carcinoma has not been well investigated, despite experimental evidence supporting an important role of vitamin D in liver pathophysiology. Our objective was to investigate the association between pre-diagnostic circulating 25-hydroxyvitamin D [25(OH)D] serum levels and risk of hepatocellular carcinoma in a prospective, nested case-control study among 520,000 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Each case (n = 138) diagnosed between 1992 and 2010 was matched to one control by age, sex, study center, date and time of blood collection, and fasting status. Serum baseline levels of 25(OH)D were measured by liquid chromatography/tandem mass spectrometry. Multivariable incident rate ratios (IRR) of hepatocellular carcinoma associated with continuous (per 10 nmol/L) or categorical levels (tertiles or a priori-defined categories) of pre-diagnostic 25(OH)D.
Higher 25(OH)D levels were associated with a 49% reduction in the risk of hepatocellular carcinoma (highest vs. lowest tertile: multivariable IRR = 0.51, 95% confidence interval, 0.26 to 0.99; Ptrend= 0.04; per 10 nmol/L increase: IRR = 0.80, 95% confidence interval, 0.68-0.94).
The finding did not vary substantially by time from enrolment to diagnosis, and did not change after adjustment for biomarkers of pre-existing liver damage, nor chronic infection with hepatitis B or C viruses. The findings were not modified by body size or smoking status.
Conclusion: In this prospective study on Western European populations, serum levels of 25(OH)D were inversely associated with risk of hepatocellular carcinoma. Given the rising incidence of this cancer in low-risk developed countries and the strong public health interest surrounding the potentially cancer-protective roles of vitamin D, additional studies in different populations are required
Stef, this is really interesting, thanks for sharing with everyone. I am trying to get out into the sun every day plus supplementing with Vit D. Not sure how much I can absorb in Feb/March and it is in the low teens, brrr, but I am going to try. Thanks again :) Dee
From my experience 5000iu daily will not hold the level. Before supplementing vit d3 my 25-oh level was always around 30 but after 10000 ui of d3 a day it came up to 80, when I changed the dose to 4000 iu it came down to 22. The level that I have never had before even bot taking D3 at all. So it may be addicted.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.